<DOC>
	<DOCNO>NCT01479010</DOCNO>
	<brief_summary>This open-label non-randomized , pilot study evaluate effect Interleukin-1 blockade exercise capacity patient pulmonary hypertension . Subjects undergo cardiopulmonary exercise test baseline , 4 week treatment Anakinra ( recombinant human Interleukin-1 receptor antagonist .</brief_summary>
	<brief_title>Pilot Study Safety Efficacy Anakinra ( Recombinant Human Interleukin-1 Receptor Antagonist ) Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Age &gt; 18 year Diagnosis PAH ( prior right heart catheterization ) , functional class III symptom right ventricle failure despite optimal PAH therapy Mean pulmonary artery pressure &gt; 25 mmHg Pulmonary capillary wedge pressure &lt; 15 mmHg Pulmonary vascular resistance &gt; 3 wood unit PAH due connective tissue disease ( include scleroderma ) , interstitial lung disease ( total lung capacity &lt; 65 % predict value ) , cirrhosis ( portopulmonary hypertension ) Angina electrocardiograph ( ECG ) change limit maximum exertion cardiopulmonary exercise test baseline ECG change limit ability detect ischemia ( i.e . leave bundlebranch block ) . Recent ( &lt; 14 day ) use antiinflammatory drug ( include NSAIDs ) , chronic inflammatory disorder ( include limit rheumatoid arthritis , systemic lupus erythematosus ) , malignancy , active infection , comorbidity limit survival ability complete study Severe kidney dysfunction ( eGFR &lt; 30 mL/min ) Thrombocytopenia ( &lt; 50,000/mm3 ) , neutropenia ( absolute neutrophil count &lt; 1,500/mm3 ) Refusal woman childbearing potential ( postmenopausal surgically sterile ) use medically acceptable form birth control ( include , limited , diaphragm , intrauterine device ( IUD ) , progesterone implant injection , oral contraceptive , doublebarrier method , condom ) throughout duration study History hypersensitivity anakinra E. coli product Latex rubber allergy Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>